The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT2 receptor

Biochemical and Biophysical Research Communications

Volumn 274, Issue 2, 2000, Pages 316-322

  Takasaki, Jun ^a   Kamohara, Masazumi ^a   Matsumoto, Mitsuyuki ^a   Saito, Tetsu ^a   Sugimoto, Toru ^a   Ohishi, Takahide ^a   Ishii, Hiroyuki ^a   Ota, Toshio ^b   Nishikawa, Tetsuo ^b   Kawai, Yuri ^b   Masuho, Yasuhiko ^b   Isogai, Takao ^b   Suzuki, Yutaka ^c   Sugano, Sumio ^c   Furuichi, Kiyoshi ^a  

^a ASTELLAS PHARMA INC   (Japan)

^b Helix Research Institute Inc   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cardiovascular system; CysLT1 receptor; CysLT2 receptor; G protein coupled receptor; Leukotriene C4; Leukotriene D4; LTC4 binding

Indexed keywords

CALCIUM; G PROTEIN COUPLED RECEPTOR; LEUKOTRIENE 1 RECEPTOR; LEUKOTRIENE 2 RECEPTOR; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR; PEPTIDOLEUKOTRIENE; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL STRAIN COS1; HEART; LEUKOCYTE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PLACENTA; PRIORITY JOURNAL; RECEPTOR GENE; SPLEEN; TISSUE DISTRIBUTION;

EID: 0034596223     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3140     Document Type: Article

References (32)

1. Lewis R. A., Austen K. F., Soberman R. J. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323:1990;645-655.
2. Piper P. J. Formation and actions of leukotrienes. Physiol. Rev. 64:1984;744-761.
3. Piper P. J., Conroy D. M., Costello J. F., Evans J. M., Green C. P., Price J. F., Sampson A. P., Spencer D. A. Leukotrienes and inflammatory lung disease. Ann. NY Acad. Sci. 629:1991;112-119.
4. Folco F., Samuelsson B., Murphy R. C. Novel Inhibitors of Leukotrienes. 1999;Birkhauser Verlag, Basel.
5. Dahlen S. E., Hedquvist P., Hammarstrom S., Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature. 288:1980;484-486.
6. Dahlen S. E. Leukotriene receptors. Clin. Rev. Allergy Immunol. 17:1999;179-191.
7. Gardiner P. J., Abram T. S., Tudhope S. R., Cuthbert N. J., Norman P., Brink C. Leukotriene receptors and their selective antagonists. Adv. Prostaglandins Thromboxane Leukot. Res. 22:1994;49-61.
8. Coleman R. A., Eglen R. M., Jones R. L., Narumiya S., Shimizu T., Smith W. L., Dahlen S. E., Drazen J. M., Gardiner P. J., Jackson W. T. Prostanoid and leukotriene receptors: A progress report from the IUPHAR working parties on classification and nomenclature. Adv. Prostaglandins. Thromboxane Leukot. Res. 23:1995;283-285.
9. Labat C., Ortiz J. L., Norel X., Gorenne I., Verley J., Abram T. S., Cuthbert N. J., Tudhope S. R., Norman P., Gardiner P. A second cysteinyl leukotriene receptor in human lung. J. Pharmacol. Exp. Ther. 263:1992;800-805.
10. Gardiner P. J., Abram T. S., Cuthbert N. J. Evidence for two leukotriene receptor types in the guinea-pig isolated ileum. Eur. J. Pharmacol. 182:1990;291-299.
11. Gardiner P. J., Norman P., Cuthbert N. J., Tudhope S. R., Abram T. S. Characterisation of the peptido-leukotriene receptor PL2 on the ferret spleen strip. Eur. J. Pharmacol. 238:1993;19-26.
12. Snyder D. W., Krell R. D. Pharmacology of peptide leukotrienes on ferret isolated airway smooth muscle. Prostaglandins. 32:1986;189-200.
13. 4 receptor in guinea-pig trachea. J. Pharmacol. Exp. Ther. 231:1984;616-622.
14. Jonsson E. W. Functional characterization of receptors for cysteinyl-leukotrienes in sheep trachealis muscle. Pulm. Pharmacol. Ther. 10:1997;29-36.
15. 1 receptor. Nature. 399:1999;789-793.
16. Sarau H. M., Ames R. S., Chambers J., Ellis C., Elshourbagy N., Foley J. J., Schmidt D. B., Muccitelli R. M., Jenkins O., Murdock P. R., Herrity N. C., Halsey W., Sathe G., Muir A. I., Nuthulaganti P., Dytko G. M., Buckley P. T., Wilson S., Bergsma D. J., Hay D. W. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol. Pharmacol. 56:1999;657-663.
17. 4 functional activity with binding affinity. Eur. J. Pharmacol. 143:1987;323-334.
18. Austen K. F., Chau L. Y., Sun F. F. Leukotriene C4 binding proteins and their implications. Adv. Prostaglandins Thromboxane Leukot. Res. 17:1987;12-19.
19. Maruyama K., Sugano S. Oligo-capping: A simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. Gene. 138:1994;171-174.
20. Suzuki Y., Yoshitomo-Nakagawa K., Maruyama K., Suyama A., Sugano S. Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library. Gene. 200:1997;149-156.
21. Salamov A. A., Nishikawa T., Swindells M. B. Assessing protein coding region integrity in cDNA sequencing projects. Bioinformatics. 14:1998;384-390.
22. Nakai K., Kanehisa M. A knowledge base for predicting protein localization sites in eukaryotic cells. Genomics. 14:1992;897-911.
23. Mizushima S., Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:1990;5322.
24. Tate S. S., Meister A. Serine-borate complex as a transition-state inhibitor of gamma-glutamyl transpeptidase. Proc. Natl. Acad. Sci. USA. 75:1978;4806-4809.
25. 4 binding site in cellular membranes. J. Biol. Chem. 269:1994;12816-12823.
26. Capra V., Nicosia S., Ragnini D., Mezzetti M., Keppler D., Rovati G. E. Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma. Mol. Pharmacol. 53:1998;750-758.
27. Feuerstein G. Cardiac and vascular effects of leukotrienes. Adv. Prostaglandins Thromboxane Leukot. Res. 16:1986;299-308.
28. 4 affects pulmonary and cardiovascular dynamics in monkey. Nature. 295:1982;327-329.
29. 4 in the intact pig heart. Am. J. Cardiol. 51:1983;1451-1454.
30. 4 in man. Int. J. Clin. Lab. Res. 27:1997;178-184.
31. Burke J. A., Levi R., Guo Z. G., Corey E. J. Effects on human and guinea-pig cardiac preparations in vitro. J. Pharmacol. Exp. Ther. 221:1982;235-241.
32. Kalachikov S., Migliazza A., Cayanis E., Fracchiolla N. S., Bonaldo M. F., Lawton L., Jelenc P., Ye X., Qu X., Chien M., Hauptschein R., Gaidano G., Vitolo U., Saglio G., Resegotti L., Brodjansky V., Yankovsky N., Zhang P., Soares M. B., Russo J., Edelman I. S., Efstratiadis A., Dalla Favera R., Fischer S. G. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. Genomics. 42:1997;369-377.